Secondary Spontaneous Pneumothorax in a COVID-19 Recovered Patient.
covid-19
covid-19 pneumonia
pneumonia
secondary pneumothorax
spontaneous pneumothorax
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
accepted:
15
07
2021
entrez:
17
8
2021
pubmed:
18
8
2021
medline:
18
8
2021
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) is an infectious disease primarily affecting the lungs with a spectrum of post-viral complications. There are well-described examples of pneumonia, empyema, pneumomediastinum, and spontaneous pneumothorax cases following COVID-19 infection within the literature. However, there is insufficient evidence implicating the cause of spontaneous pneumothorax in COVID-19 recovered patients. We present a previously infected COVID-19 patient who developed a secondary spontaneous pneumothorax two weeks after recovering. A review of the literature for similar cases was limited and therefore includes a summary of recommendations. Overall, the literature establishes that pneumothorax can occur during different phases of COVID-19 in patients without a history of pulmonary disease or barotrauma and is not necessarily associated with the severity of the viral infection. As in the case of our patient, the culmination of chronic inflammatory changes and an acute exacerbation from COVID-19 further predisposed him to a secondary spontaneous pneumothorax. In summary, all cases of recovered COVID-19 patients should maintain close follow-up with their physician and seek medical attention if acute respiratory symptoms develop.
Identifiants
pubmed: 34401214
doi: 10.7759/cureus.16415
pmc: PMC8364669
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e16415Informations de copyright
Copyright © 2021, Sahagun et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Respir Med Case Rep. 2020;31:101187
pubmed: 32837901
Case Rep Pulmonol. 2015;2015:201051
pubmed: 25688319
Am J Trop Med Hyg. 2020 Sep;103(3):1170-1176
pubmed: 32705978
J Infect Public Health. 2020 Jun;13(6):887-889
pubmed: 32475804
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Eur Respir J. 2020 Nov 19;56(5):
pubmed: 32907891
Case Rep Crit Care. 2021 Jan 11;2021:6657533
pubmed: 33505730
Signal Transduct Target Ther. 2020 Oct 15;5(1):240
pubmed: 33060566
Am J Trop Med Hyg. 2020 Sep;103(3):1166-1169
pubmed: 32662394
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Medicina (Kaunas). 2021 Jan 20;57(2):
pubmed: 33498180
Respir Res. 2020 Sep 16;21(1):236
pubmed: 32938445
Respir Med. 2010 Oct;104(10):1391-5
pubmed: 20638828
Ann Thorac Surg. 2010 Oct;90(4):1363-5
pubmed: 20868851
BMJ Case Rep. 2021 Jan 18;14(1):
pubmed: 33462033
Korean J Radiol. 2020 May;21(5):541-544
pubmed: 32207255
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32330274
Intern Med. 2020 Nov 15;59(22):2921-2925
pubmed: 33028774
BMC Pulm Med. 2021 Jan 12;21(1):24
pubmed: 33435949
Medicine (Baltimore). 2020 May;99(18):e20175
pubmed: 32358406